Switch theme
Sign up to access all valuation multiples
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning most of its revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The industrial product segment manufactures and sells grinders for manual works and spindles for machinery attachment. The others segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
1981
1.4K+
LTM Revenue $541M
LTM EBITDA $139M
$943M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nakanishi has a last 12-month revenue (LTM) of $541M and a last 12-month EBITDA of $139M.
In the most recent fiscal year, Nakanishi achieved revenue of $529M and an EBITDA of $134M.
Nakanishi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nakanishi valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $541M | XXX | $529M | XXX | XXX | XXX |
| Gross Profit | $309M | XXX | $305M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $139M | XXX | $134M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| EBIT | $100.0M | XXX | $100M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $62.7M | XXX | $58.9M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nakanishi's stock price is JPY 1938 (or $13).
Nakanishi has current market cap of JPY 162B (or $1.1B), and EV of JPY 137B (or $943M).
See Nakanishi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $943M | $1.1B | XXX | XXX | XXX | XXX | $0.74 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nakanishi has market cap of $1.1B and EV of $943M.
Nakanishi's trades at 1.8x EV/Revenue multiple, and 7.0x EV/EBITDA.
Equity research analysts estimate Nakanishi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nakanishi has a P/E ratio of 17.7x.
See valuation multiples for Nakanishi and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $943M | XXX | $943M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 6.8x | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBIT | 9.4x | XXX | 9.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 17.7x | XXX | 18.9x | XXX | XXX | XXX |
| EV/FCF | 18.9x | XXX | 13.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNakanishi's last 12 month revenue growth is 6%
Nakanishi's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Nakanishi's rule of 40 is 61% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nakanishi's rule of X is 42% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nakanishi and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | -21% | XXX | XXX | XXX |
| Rule of 40 | 61% | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 42% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nakanishi acquired XXX companies to date.
Last acquisition by Nakanishi was XXXXXXXX, XXXXX XXXXX XXXXXX . Nakanishi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nakanishi founded? | Nakanishi was founded in 1981. |
| Where is Nakanishi headquartered? | Nakanishi is headquartered in Japan. |
| How many employees does Nakanishi have? | As of today, Nakanishi has 1.4K+ employees. |
| Who is the CEO of Nakanishi? | Nakanishi's CEO is Mr. Eiichi Nakanishi. |
| Is Nakanishi publicy listed? | Yes, Nakanishi is a public company listed on TKS. |
| What is the stock symbol of Nakanishi? | Nakanishi trades under 7716 ticker. |
| When did Nakanishi go public? | Nakanishi went public in 2013. |
| Who are competitors of Nakanishi? | Similar companies to Nakanishi include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nakanishi? | Nakanishi's current market cap is $1.1B |
| What is the current revenue of Nakanishi? | Nakanishi's last 12 months revenue is $541M. |
| What is the current revenue growth of Nakanishi? | Nakanishi revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Nakanishi? | Current revenue multiple of Nakanishi is 1.7x. |
| Is Nakanishi profitable? | Yes, Nakanishi is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nakanishi? | Nakanishi's last 12 months EBITDA is $139M. |
| What is Nakanishi's EBITDA margin? | Nakanishi's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Nakanishi? | Current EBITDA multiple of Nakanishi is 6.8x. |
| What is the current FCF of Nakanishi? | Nakanishi's last 12 months FCF is $50.0M. |
| What is Nakanishi's FCF margin? | Nakanishi's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Nakanishi? | Current FCF multiple of Nakanishi is 18.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
